GPhC advises pharmacy teams to comply if asked by contact tracers to self-isolate
The General Pharmaceutical Council (GPhC) has advised pharmacy teams to self-isolate if asked to do so by the contact tracers to "protect themselves, their colleagues...
Over half of pregnant women in hospital due to coronavirus were from BAME backgrounds: study
More than half the number of pregnant women who were admitted to UK hospitals with coronavirus were from a black, Asian or minority ethnic...
People should wear face-coverings when visiting community pharmacies: RPS
The Royal Pharmaceutical Society has called for consistency in the use of face coverings across primary care and hospitals to "provide maximum protection from the...
Lockdowns may have averted three million deaths in Europe by curbing COVID-19, researchers say
Wide-scale lockdowns including shop and school closures have reduced COVID-19 transmission rates in Europe enough to control its spread and may have averted more...
Lonza picks Roche top executive as CEO
Lonza Group on Friday (June 5) named a veteran Roche manager to become its new chief executive, as the Swiss contract drug manufacturer seeks...
AstraZeneca ‘on track’ to roll out virus vaccine in September
British pharma giant AstraZeneca is "on track" to begin rolling out up to two billion doses of a coronavirus vaccine in September if ongoing trials prove...
UK virus death toll tops 40,000
Britain's official coronavirus death toll has topped 40,000, after the government on Friday (June 5) reported a further 357 fatalities in the last 24...
UK virus reproduction number unchanged overall
The reproduction number of Covid-19 in the UK remains between 0.7 and 0.9, government scientists said on Friday (June 5), but has increased in...
PDA welcomes Boots’ confirmation on provisionally registered pharmacists’ pay
The Pharmacy Defence Association (PDA) has welcomed Boots' confirmation that provisionally registered (prov-regs) pharmacists will receive the same salary as newly-qualified pharmacists.
Prov-regs at Boots...
UK halts trial of ‘useless’ hydroxychloroquine in COVID-19 patients
British scientists today (June 5) halted a large trial that had been exploring the use of the anti-malaria drug hydroxychloroquine in patients with the...
Current Issue March 2024
